Carbonic Anhydrase II

Carbonic Anhydrase II Molekülinformation

Englischer NameCarbonic anhydrase IIAnzahl der inverkehr gebrachten Arzneimittel5
Anzahl der klinischen Arzneimittel1Target-AliasCarbonic anhydrase II,Carbonic Anhydrase B,EC:4.2.1.1,Carbonate Dehydratase II,Carbonic Anhydrase C,EC 4.2.1.1,CA2,Epididymis Luminal Protein 76,Car2,HEL-76,Epididymis Secretory Protein Li 282,CA-II,CAC,CAII,HEL-S-282,Carbonic Anhydrase 2,Carbonic Dehydratase
Höchste Forschungs- und EntwicklungsphaseApproved
Englischer NameCarbonic anhydrase II
Target-AliasCarbonic anhydrase II,Carbonic Anhydrase B,EC:4.2.1.1,Carbonate Dehydratase II,Carbonic Anhydrase C,EC 4.2.1.1,CA2,Epididymis Luminal Protein 76,Car2,HEL-76,Epididymis Secretory Protein Li 282,CA-II,CAC,CAII,HEL-S-282,Carbonic Anhydrase 2,Carbonic Dehydratase
Anzahl der inverkehr gebrachten Arzneimittel5
Anzahl der klinischen Arzneimittel1
Höchste Forschungs- und EntwicklungsphaseApproved

Carbonic Anhydrase II Produktliste

  • Attribut

    Protein (1)

  • Produktbibliothek

    Online (1)

  • Spezies

    Human (1)

  • Etikett

    His Tag (1)

  • Marker

    Unconjugated (1)

ProduktnummerSpeziesExpressionssystemProduktbeschreibungProteinstrukturReinheitEigenschaftenVorbestellen/Bestellen
Human
HEK293
Human Carbonic Anhydrase II / CA2 Protein, His Tag (active enzyme)
In den Warenkorb legen
Gesamtmenge1
  • 1

Carbonic Anhydrase II Molekülhintergrund

Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes. CAs form a family of enzymes that catalyze the rapid interconversion of carbon dioxide and water to bicarbonate and protons (or vice versa), a reversible reaction that occurs rather slowly in the absence of a catalyst. One of the functions of the enzyme in animals is to interconvert carbon dioxide and bicarbonate to maintain acid-base balance in blood and other tissues, and to help transport carbon dioxide out of tissues. The active site of most carbonic anhydrases contains a zinc ion. They are, therefore, classified as metalloenzymes. There are at least five distinct CA families (α, β, γ, δ and ε). These families have no significant amino acid sequence similarity and in most cases are thought to be an example of convergent evolution. The α-CAs are found in humans. Carbonic anhydrase II (CA2) is also known as Carbonate dehydratase II, Carbonic anhydrase C, is one of fourteen forms of human α carbonic anhydrases. Defects in this enzyme are associated with osteopetrosis and renal tubular acidosis. Renal carbonic anhydrase allows the reabsorption of sodium ions in the proximal tubule. Carbonic anhydrase II has been shown to interact with Band 3 and Sodium-hydrogen antiporter 1.

Carbonic Anhydrase II Molekülalias

CA2,CA-II,CAII,Car2

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
Topiramate (PrevEp)PrevEp-004Phase 2 ClinicalPrevEP IncEpilepsy, Benign Neonatal; Status Epilepticus
Details

Inverkehr gebrachte Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaFrühestes MarkennameFrühestes GenehmigungslandFrüheste IndikationFrüheste GenehmigungsgesellschaftFrüheste GenehmigungsdatumIndikationenKlinische Studie
Brinzolamide/Timolol MaleateApprovedAlconAzarga, ElazopEUOcular Hypertension; Glaucoma, Open-AngleNovartis Europharm Ltd2008-11-25Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension
Details
SultiameRiker-594ApprovedDesitin Arzneimittel GmbhOspolotJapanEpilepsyKyowa Pharmaceutical Industry Co Ltd2001-12-01Epilepsy; Sleep Apnea, Obstructive
Details
Brinzolamide/Brimonidine TartrateApprovedNovartis Pharma AgSimbrinzaUnited StatesOcular Hypertension; Glaucoma, Open-AngleAlcon Laboratories Inc2013-04-19Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension
Details
TopiramateSPN-538; KW-6485P; McN-4853; RWJ-17021; W-6485; TPM; USL-255ApprovedJohnson & Johnson Innovative Medicine妥泰, Topamax, Topina, Conviban, Qudexy, EprontiaUnited KingdomMigraine Disorders; EpilepsyJohnson & Johnson Innovative Medicine1995-01-01Affective Disorders, Psychotic; Alcohol Drinking; Alcoholism; Binge-Eating Disorder; Bipolar Disorder; Brain Ischemia; Bulimia; Cocaine-Related Disorders; Cognition; Contraception; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Epilepsies, Partial; Epilepsy; Epilepsy, Absence; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Essential Tremor; Gambling; Headache; Heart Defects, Congenital; HIV Infections; Hyperlipidemias; Hypertension; Hypertriglyceridemia; Lennox Gastaut Syndrome; Lymphoma; Marijuana Abuse; Mental Disorders; Migraine Disorders; Migraine with Aura; Migraine without Aura; Mood Disorders; Obesity; Obesity, Morbid; Obsessive-Compulsive Disorder; Pain, Postoperative; Parkinson Disease; Pediatric Obesity; Peripheral Nervous System Diseases; Polyneuropathies; Sciatica; Seizures; Stress Disorders, Post-Traumatic; Tobacco Use Disorder; Tourette Syndrome; Vascular Headaches; Weight Loss
Details
BrinzolamideAL-4862; ALO-4862ApprovedAlcon派立明, AzoptUnited StatesOcular Hypertension; Glaucoma, Open-AngleSandoz1998-04-01Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension
Details
  • Molekülinformation
  • Produktliste
  • Inverkehr gebrachte Arzneimittelinformation
  • Klinische Arzneimittelinformation